On Monday, Oct. 8, my First Year Seminar, Writing with Pictures: An Introduction to Writing Picture Books and Graphic Novels, ...

From transformative weight loss treatment to a potential blockbuster for Alzheimer's, Dave Ricks of Eli Lilly is having a ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 519.47% and ...

More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs ...

Monday’s edition of Forbes Daily covers fresh records for S&P 500 and bitcoin, gambling in the UAE, Musk surpasses $300B, open questions for H-1B visa holders and more.

The reactions to Donald's Trump's victory across the crypto, currency, and stock markets. Super Micro's woes, and the outlook for a company with no auditor, no annual report and, perhaps soon, no ...

A weight drug recently legalised in the UK contributed to the death of a 58-year-old nurse, according to a new report.

Viking Therapeutics released new data on an obesity pill that may eventually compete with blockbuster shots from Eli Lilly and Novo Nordisk, stoking further takeout speculation for the company.

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other S&P 500 stocks. As per AXA Investment Managers, the US dominated financial markets this ...

But earnings in the new range would still wind up being more than twice what the company registered for 2023. Shares of Indianapolis-based Eli Lilly and Co. were down 6%, or $57.02, to $846.56 in ...

Skyrocketing demand for injectable weight loss and diabetes drugs has forced both Eli Lilly and its main rival, Novo Nordisk, to invest billions to increase manufacturing capacity. The company's ...

Eli Lilly executives insisted that underlying demand for the medicines remained strong and that the company has enough supply available. The reason for the disappointing sales, according to the ...